You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Healthera secures £2m strategic investment to accelerate digital pharmacy platform growth and North American expansion
- 2. RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING'S SYNDROME
- 3. Transcriptome sequencing revealed that lymph node metastasis of papillary thyroid microcarcinoma is associated with high THBS4 expression and PDGFRA+ cancer-associated fibroblasts
- 4. SECuRE trial update: First patient treated in the Phase II Cohort Expansion
- 5. Temporal dynamics of lymphocytes in prostate cancer patients treated with proton therapy
- 6. Meta-analysis of medical cannabis outcomes and associations with cancer
- 7. Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
- 8. Identifying antisense oligonucleotides for targeted inhibition of insulin receptor isoform A
- 9. Study shows how new antibody therapy works against ovarian cancer
- 10. Disrupting calcium homeostasis and glycometabolism in engineered lipid-based pharmaceuticals propel cancer immunogenic death
Last updated at 22:37 GMT
Hot News Makers
Health/Pharma Companies
-
287058.21
-
23193.58
-
12679.95
-
10558.30
-
10192.63
-
8208.49
-
6007.13
-
5790.54
-
5632.79
-
5396.58
Drugs, Treatments, Trials
-
21925.47
-
8656.33
-
7936.73
-
7531.57
-
6941.20
-
6241.27
-
5451.36
-
4515.48
-
4211.12
-
4013.76
Last updated at 22:10 GMT
